Please login to the form below

Not currently logged in
Email:
Password:

Cancer Insights

This page shows the latest Cancer Insights news and features for those working in and with pharma, biotech and healthcare.

Pharma shares data on cancer projects

Pharma shares data on cancer projects

Cancer Centre in the US - designed to collect cancer research data in a single location. ... Howard Scher, chief of the genitourinary oncology service at Memorial Sloan Kettering Cancer Centre, said the PDS: "will enable the research community to bring

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Oncology drugs under AMNOG: part two Oncology drugs under AMNOG: part two

    Patient-relevant outcomes and the 'added benefit' of cancer drugs. We conclude our look at AMNOG and cancer drugs with some insights from the benefit assessment process and focus on the ... Analysis of decisions on cancer drugs over the past three years

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics